Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free LFST Stock Alerts

LifeStance Health Group (LFST) Competitors

LifeStance Health Group logo
$10.96 +0.18 (+1.62%)
As of 03:59 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

LFST vs. BTSG, FMS, HIMS, PACS, and BLLN

Should you buy LifeStance Health Group stock or one of its competitors? MarketBeat compares LifeStance Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with LifeStance Health Group include BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), PACS Group (PACS), and Billiontoone (BLLN). These companies are all part of the "healthcare" industry.

How does LifeStance Health Group compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and LifeStance Health Group (NASDAQ:LFST) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation, dividends and media sentiment.

In the previous week, BrightSpring Health Services had 9 more articles in the media than LifeStance Health Group. MarketBeat recorded 16 mentions for BrightSpring Health Services and 7 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.59 beat BrightSpring Health Services' score of 0.44 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
4 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

BrightSpring Health Services has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market.

BrightSpring Health Services has higher revenue and earnings than LifeStance Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B1.04$190.67M$1.4148.30
LifeStance Health Group$1.42B2.97$9.66M$0.06182.07

BrightSpring Health Services has a net margin of 2.27% compared to LifeStance Health Group's net margin of 1.55%. BrightSpring Health Services' return on equity of 14.63% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
LifeStance Health Group 1.55%1.56%1.07%

BrightSpring Health Services presently has a consensus target price of $70.12, suggesting a potential upside of 2.96%. LifeStance Health Group has a consensus target price of $10.75, suggesting a potential downside of 1.59%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, equities research analysts clearly believe BrightSpring Health Services is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
3.00
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

85.5% of LifeStance Health Group shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

BrightSpring Health Services beats LifeStance Health Group on 11 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

LifeStance Health Group (NASDAQ:LFST) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

LifeStance Health Group has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than LifeStance Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B2.97$9.66M$0.06182.07
Fresenius Medical Care AG & Co. KGaA$19.36B0.67$1.11B$1.9012.67

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to LifeStance Health Group's net margin of 1.55%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group1.55% 1.56% 1.07%
Fresenius Medical Care AG & Co. KGaA 4.88%8.90%4.05%

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

LifeStance Health Group currently has a consensus target price of $10.75, suggesting a potential downside of 1.59%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, suggesting a potential upside of 16.33%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
Fresenius Medical Care AG & Co. KGaA
4 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.56

In the previous week, LifeStance Health Group had 3 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 7 mentions for LifeStance Health Group and 4 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.26 beat LifeStance Health Group's score of 0.59 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

LifeStance Health Group beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

LifeStance Health Group has a net margin of 1.55% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
LifeStance Health Group 1.55%1.56%1.07%

Hims & Hers Health has a beta of 2.35, indicating that its share price is 135% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.12, indicating that its share price is 12% more volatile than the broader market.

Hims & Hers Health has higher revenue and earnings than LifeStance Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B3.66$128.37M-$0.09N/A
LifeStance Health Group$1.42B2.97$9.66M$0.06182.07

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Hims & Hers Health currently has a consensus target price of $30.70, suggesting a potential downside of 17.33%. LifeStance Health Group has a consensus target price of $10.75, suggesting a potential downside of 1.59%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, analysts clearly believe LifeStance Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

In the previous week, Hims & Hers Health had 3 more articles in the media than LifeStance Health Group. MarketBeat recorded 10 mentions for Hims & Hers Health and 7 mentions for LifeStance Health Group. Hims & Hers Health's average media sentiment score of 0.99 beat LifeStance Health Group's score of 0.59 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Hims & Hers Health beats LifeStance Health Group on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to PACS Group?

PACS Group (NYSE:PACS) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

PACS Group has a beta of -0.08, suggesting that its stock price is 108% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market.

85.5% of LifeStance Health Group shares are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, PACS Group had 2 more articles in the media than LifeStance Health Group. MarketBeat recorded 9 mentions for PACS Group and 7 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.59 beat PACS Group's score of 0.49 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
3 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

PACS Group currently has a consensus price target of $50.60, suggesting a potential upside of 12.31%. LifeStance Health Group has a consensus price target of $10.75, suggesting a potential downside of 1.59%. Given PACS Group's higher possible upside, equities research analysts plainly believe PACS Group is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

PACS Group has a net margin of 4.49% compared to LifeStance Health Group's net margin of 1.55%. PACS Group's return on equity of 26.47% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
LifeStance Health Group 1.55%1.56%1.07%

PACS Group has higher revenue and earnings than LifeStance Health Group. PACS Group is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.35$191.54M$1.5628.88
LifeStance Health Group$1.42B2.97$9.66M$0.06182.07

Summary

PACS Group beats LifeStance Health Group on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and LifeStance Health Group (NASDAQ:LFST) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Billiontoone had 8 more articles in the media than LifeStance Health Group. MarketBeat recorded 15 mentions for Billiontoone and 7 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.59 beat Billiontoone's score of 0.37 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
LifeStance Health Group
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Billiontoone currently has a consensus target price of $126.00, indicating a potential downside of 2.24%. LifeStance Health Group has a consensus target price of $10.75, indicating a potential downside of 1.59%. Given LifeStance Health Group's stronger consensus rating and higher possible upside, analysts clearly believe LifeStance Health Group is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

LifeStance Health Group has higher revenue and earnings than Billiontoone. LifeStance Health Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$354.54M16.72$7.45M$0.55234.35
LifeStance Health Group$1.42B2.97$9.66M$0.06182.07

LifeStance Health Group has a net margin of 1.55% compared to Billiontoone's net margin of 0.00%. LifeStance Health Group's return on equity of 1.56% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
BilliontooneN/A N/A N/A
LifeStance Health Group 1.55%1.56%1.07%

Summary

LifeStance Health Group beats Billiontoone on 11 of the 15 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFST vs. The Competition

Export
MetricLifeStance Health GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$4.24B$6.25B$6.79B$12.62B
Dividend YieldN/A1.42%2.68%8.42%
P/E Ratio182.2541.2027.1124.33
Price / Sales2.9730.35523.7290.61
Price / Cash64.6819.2248.5959.39
Price / Book2.793.7410.856.31
Net Income$9.66M$218.81M$3.59B$331.45M
7 Day Performance4.14%1.17%-1.34%-0.04%
1 Month Performance27.17%13.81%2.99%-0.88%
1 Year Performance148.27%38.36%28.94%20.43%

LifeStance Health Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFST
LifeStance Health Group
3.1486 of 5 stars		$10.97
+1.6%		$10.75
-2.0%		+136.1%$4.24B$1.42B182.4210,961
BTSG
BrightSpring Health Services
3.3189 of 5 stars		$69.67
+0.0%		$70.12
+0.6%		+243.0%$13.75B$12.91B49.4123,500
FMS
Fresenius Medical Care AG & Co. KGaA
4.2758 of 5 stars		$24.16
-1.2%		$28.00
+15.9%		-11.1%$12.97B$22.20B12.711,488
HIMS
Hims & Hers Health
3.3084 of 5 stars		$35.14
+2.2%		$30.70
-12.6%		-32.4%$8.13B$2.35BN/A2,442
PACS
PACS Group
2.9758 of 5 stars		$44.81
+3.6%		$50.60
+12.9%		+246.7%$7.09B$5.29B28.7347,455

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:LFST) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel